VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 103 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 150 | -62.5% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +33.3% | 400 | -38.5% | 0.00% | – |
| Q4 2018 | $6,000 | -50.0% | 650 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 650 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +8.3% | 650 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | 0.0% | 750 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,000 | -7.7% | 750 | +15.4% | 0.00% | 0.0% |
| Q3 2017 | $13,000 | +62.5% | 650 | +62.5% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |